Compare VALN & IFN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | VALN | IFN |
|---|---|---|
| Founded | 2012 | N/A |
| Country | France | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Finance/Investors Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 537.8M | 540.6M |
| IPO Year | 2021 | 1994 |
| Metric | VALN | IFN |
|---|---|---|
| Price | $6.10 | $11.04 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 4 | 0 |
| Target Price | ★ $15.75 | N/A |
| AVG Volume (30 Days) | 128.2K | ★ 265.6K |
| Earning Date | 05-06-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $4.00 | N/A |
| Revenue Next Year | $92.04 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $5.43 | $10.84 |
| 52 Week High | $12.25 | $16.60 |
| Indicator | VALN | IFN |
|---|---|---|
| Relative Strength Index (RSI) | 25.51 | 31.28 |
| Support Level | $5.69 | N/A |
| Resistance Level | $6.73 | $15.31 |
| Average True Range (ATR) | 0.38 | 0.25 |
| MACD | -0.33 | 0.02 |
| Stochastic Oscillator | 1.11 | 16.14 |
Valneva SE is a vaccine company focused on developing life-saving vaccines. Its portfolio includes three vaccines for travelers. The segments of the group are Commercialized vaccines which relate to marketed vaccines, the group's vaccines IXIARO/JESPECT, DUKORAL, IXCHIQ; Covid includes development, manufacturing, & distribution related to the COVID-19 vaccine, Vaccine candidates which relate to research and development programs to generate new approvable products to generate future cash flows from product sales through partnering with pharmaceutical companies; & Technologies and services which relate to services and inventions at a commercialization stage. The company generates majority of its revenue from product sales.
India Fund Inc is an asset management company. The fund's investment objective is long-term capital appreciation, which it seeks to achieve by investing in the equity securities of Indian companies. The company's portfolio is a non-diversified closed-end management investment company across various sectors such as financials, consumer staples, information technology, materials, healthcare, consumer discretionary, industrials, telecommunication services, utilities, and others. Geographically, all the business activity functions through the market of the United States.